Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Pneumologie ; 72(5): 347-392, 2018 May.
Artigo em Alemão | MEDLINE | ID: mdl-29758578

RESUMO

Cystic Fibrosis (CF) is the most common autosomal-recessive genetic disease affecting approximately 8000 people in Germany. The disease is caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene leading to dysfunction of CFTR, a transmembrane chloride channel. This defect causes insufficient hydration of the epithelial lining fluid which leads to chronic inflammation of the airways. Recurrent infections of the airways as well as pulmonary exacerbations aggravate chronic inflammation, lead to pulmonary fibrosis and tissue destruction up to global respiratory insufficiency, which is responsible for the mortality in over 90 % of patients. The main aim of pulmonary treatment in CF is to reduce pulmonary inflammation and chronic infection. Pseudomonas aeruginosa (Pa) is the most relevant pathogen in the course of CF lung disease. Colonization and chronic infection are leading to additional loss of pulmonary function. There are many possibilities to treat Pa-infection. This is a S3-clinical guideline which implements a definition for chronic Pa-infection and demonstrates evidence-based diagnostic methods and medical treatment for Pa-infection in order to give guidance for individual treatment options.


Assuntos
Regulador de Condutância Transmembrana em Fibrose Cística/genética , Fibrose Cística/diagnóstico , Fibrose Cística/terapia , Guias de Prática Clínica como Assunto , Pseudomonas aeruginosa/isolamento & purificação , Fibrose Cística/complicações , Fibrose Cística/microbiologia , Regulador de Condutância Transmembrana em Fibrose Cística/metabolismo , Alemanha , Humanos , Infecções por Pseudomonas/diagnóstico
3.
Pneumologie ; 70(9): 605-7, 2016 Sep.
Artigo em Alemão | MEDLINE | ID: mdl-27603949

RESUMO

UNLABELLED: A patient presented himself with pungent, breath-dependent right chest pain and dyspnea at rest in our emergency department. The physical examination and the ECG revealed no relevant findings. The laboratory results showed an increased CRP, leukocytosis, elevated D-dimers and a respiratory partial insufficiency. In the thoracic CT angiography unclear pulmonary nodules (PN) were seen. The bronchoscopy was macroscopically normal. In the BAL yeasts and a high proportion of immune senescence cells (CD57+) were identified. After a pulmonary wedge resection resulted histologically an epithelioid cell-granulomatous inflammation. Molecular pathological a mycelium genome, in particular Pichia guilliermondii (PC) was detected. The therapy with fluconazole was successful. PC rarely causes candidemia, increased in immunocompromised patients. In our judgement this is in Europe the first described case of PC-infection in a patient, which presented no predisposition to infection with opportunistic pathogens apart from type 2 diabetes. CONCLUSION: It should be thought of fungal infection by these pathogens group in case of unclear PN, especially in combination with possibly predisposing factors.


Assuntos
Fungemia/diagnóstico , Fungemia/microbiologia , Pneumopatias Fúngicas/diagnóstico , Pneumopatias Fúngicas/microbiologia , Nódulos Pulmonares Múltiplos/diagnóstico , Nódulos Pulmonares Múltiplos/microbiologia , Pichia/classificação , Pichia/isolamento & purificação , Diagnóstico Diferencial , Humanos , Masculino , Pessoa de Meia-Idade , Doenças Raras
6.
Clin Microbiol Infect ; 15(5): 454-60, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19196263

RESUMO

Pseudomonas aeruginosa and Staphylococcus aureus are thought to cause the majority of lung infections in patients with cystic fibrosis (CF). However, other bacterial pathogens may contribute to the pathophysiology of lung disease. Here, obligate anaerobes were identified in a cross-sectional study, and cell numbers and antibiotic susceptibilities of facultative and obligate anaerobes from 114 sputum samples from nine children and 36 adults with CF were determined. Furthermore, in 12 CF patients, we investigated whether conventional intravenous antibiotic therapy, administered during acute exacerbations, would affect the numbers of obligate anaerobes. Fifteen genera of obligate anaerobes were identified in 91% of the CF patients. Cell numbers (mean: 2.2 x 10(7) +/- standard deviation 6.9 x 10(7) CFU/mL of sputum sample) were comparable to those of P. aeruginosa and S. aureus. Staphylococcus saccharolyticus and Peptostreptococcus prevotii were most prevalent. Infection with P. aeruginosa did not increase the likelihood that obligate anaerobes are present in sputum specimens. Single obligate anaerobic species persisted for up to 11 months in sputum plugs in vivo. Patients with and without obligate anaerobes in sputum specimens did not differ in lung function. Intravenous therapy directed against P. aeruginosa during acute exacerbations increased lung function, but did not reduce the numbers of obligate anaerobes. Obligate anaerobic species differed widely in their patterns of resistance against meropenem, piperacillin-tazobactam, clindamycin, metronidazole and ceftazidime. In 58% of patients with acute exacerbations, obligate anaerobes were detected that were resistant to the antibiotics used for treatment. Antibiotic therapy, optimized to target anaerobes in addition to P. aeruginosa, may improve the management of CF lung disease.


Assuntos
Bactérias Anaeróbias/efeitos dos fármacos , Bactérias Anaeróbias/isolamento & purificação , Infecções Bacterianas/microbiologia , Fibrose Cística/complicações , Adolescente , Adulto , Antibacterianos/uso terapêutico , Criança , Contagem de Colônia Microbiana , Estudos Transversais , Farmacorresistência Bacteriana , Feminino , Humanos , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Escarro/microbiologia , Adulto Jovem
7.
Mund Kiefer Gesichtschir ; 7(3): 151-6, 2003 May.
Artigo em Alemão | MEDLINE | ID: mdl-12764681

RESUMO

BACKGROUND: The present study analyzed the memory effect of resorbable polymers. Depending on temperature, this effect describes the ability of different materials to "remember" their original form after mechanical deformation. Resorbable polymers serve as materials to stabilize and fix bone fractures. Compared to metal transplants, resorbable polymers are able to undergo thermoplastic deformation. The precise adaptation of the transplant to the surrounding bone guarantees an exact anatomical reconstruction. However, during normal applications, it was observed that these biodegradable plastic materials tend to revert to their original form at body temperature. This "memory effect" could result in negative consequences for the medical treatment. METHODS: By the process of compression molding, geometrically formed specimens (lattice, rod, plate) consisting of different polyglycolides and polylactides were prepared. After warming up the specimens to 50 degrees C (water bath) they were deformed into definite angles. Following this procedure, the specimens were put in a water bath at 37 degrees C to mimic the adaptation of the transplant at body temperature. The retroflexion of the material (memory effect) was measured using an XY-measuring desk. RESULTS: The present study clearly reveals that highly deformed specimens react with stronger retroflexions. In addition, the results indicate that the memory effect depends on geometrical design as well as on chemical composition. All tested polymers showed a strong initial memory effect that decreased with time.


Assuntos
Implantes Absorvíveis , Pinos Ortopédicos , Placas Ósseas , Fixação Interna de Fraturas/instrumentação , Ácido Láctico , Poliésteres , Ácido Poliglicólico , Polímeros , Fenômenos Biomecânicos , Desenho de Equipamento , Humanos , Teste de Materiais , Copolímero de Ácido Poliláctico e Ácido Poliglicólico , Temperatura
8.
HNO ; 50(5): 483-7, 2002 May.
Artigo em Alemão | MEDLINE | ID: mdl-12089815

RESUMO

Primary ciliary dyskinesia syndrome (PCD) is a rare, autosomal receive disorder. Kartagener's syndrome is a subgroup of the PCD with situs inversus, bronchiectasis, and sinusitis. The symptoms results from an abnormal ultrastructural morphology of the cilia such as absence of dynein arms and other changes. As a consequence ciliary motility is disturbed. A 25-year-old man was examined because he suffered from recurrent severe pneumonia and Aspergillus infections of the lungs. On electron micrographs, ciliary abnormalities including deficiency of inner and outer dynein arms, dysmorphic outer dynein arms, and disorientation of the cilia were demonstrated. The diagnosis of PCD requires electron-microscopic investigations of the ciliated mucosa. Special attention should be given to ultrastructural changes of nasal or bronchial mucosa if a young patient suffers from recurrent severe respiratory infections.


Assuntos
Aspergilose/patologia , Broncopneumonia/patologia , Transtornos da Motilidade Ciliar/patologia , Pneumopatias Fúngicas/patologia , Depuração Mucociliar/fisiologia , Mucosa Nasal/patologia , Adulto , Aspergilose/genética , Broncopneumonia/genética , Aberrações Cromossômicas , Transtornos da Motilidade Ciliar/genética , Genes Recessivos/genética , Humanos , Pneumopatias Fúngicas/genética , Masculino , Microscopia Eletrônica , Depuração Mucociliar/genética , Recidiva , Vesículas Secretórias/ultraestrutura , Tomografia Computadorizada por Raios X
9.
Clin Drug Investig ; 21(3): 161-8, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-27517545

RESUMO

BACKGROUND: Docetaxel has shown promising single-agent activity in non-small cell lung cancer (NSCLC) and its activity can be enhanced by the addition of platinum compounds. Several studies indicate that carboplatin may be as effective as cisplatin but with better tolerability. OBJECTIVE: A phase II study was performed to investigate the safety and efficacy of combination chemotherapy with docetaxel and carboplatin in patients with advanced NSCLC. PATIENTS AND METHODS: 30 chemotherapy-naïve patients with stage IIIB and IV NSCLC were treated with docetaxel 90 mg/m(2) over 1 hour, followed by carboplatin administered according to a target area under the curve of 5 mg/ml/min (Calvert's formula). Treatment was repeated every 3 weeks for 6 cycles. RESULTS: Myelosuppression was the predominant toxicity. Grade 3 or 4 granulocytopenia occurred in 77% of the patients. However, granulocyte colony-stimulating factor (G-CSF) was not utilised and neutropenic fever did not occur. Grade 3 or 4 nail disorder developed in 27% of the patients. Other non-haematological toxicities, including fluid retention, were mild to moderate. The objective response rate was 30% (two complete and seven partial responses). The median time to progression was 24 weeks and median survival 57 weeks. One-year survival was 56%. CONCLUSIONS: The combination of docetaxel and carboplatin appears to be well tolerated and active in patients with advanced NSCLC.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA